Browsing by Subject Alzheimer's disease (AD)
Showing results 1 to 10 of 10
| Issue Date | Title | Author(s) |
| 2022-01 | Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective | Tare, Meghana |
| 2024-08 | Design, synthesis, in silico, and in vitro evaluation of pyrrol-2-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors | Jadhav, Hemant R. |
| 2023-02 | Editorial: Protein misfolding, altered mechanisms and neurodegeneration | Tare, Meghana |
| 2022-03 | Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's | Pandey, Murali Monohar |
| 2018 | Epigenetic mechanisms in Alzheimer's Disease: Therapeutic potential of Class specific HDAC inhibitors in insulin resistance induced cognitive impairments | Taliyan, Rajeev |
| 2021-12 | Fibroblast Growth Factor 21 and Autophagy Modulation Ameliorates Amyloid β-Induced Alzheimer Disease Pathology in Rats | Taliyan, Rajeev |
| 2017-07 | [P2–130]: AR-A014418, A GSK-3β INHIBITOR, ATTENUATES ALZHEIMER'S- LIKE PATHOLOGY IN HIGH FAT DIET-INDUCED COGNITIVE DEFICIT IN MICE | Taliyan, Rajeev |
| 2024-12 | Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective | Jadhav, Hemant R. |
| 2024-12 | Structure-based virtual screening and biological characterization of novel bace-1 and amyloid-β aggregation inhibitors | Jadhav, Hemant R. |
| 2024-07 | Unveiling the potential of novel indol-3-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors: a combined in silico, synthesis and in vitro study | Jadhav, Hemant R. |
